IPVS webinar – The Future of HPV research
IPVS webinar – The Future of HPV research, featuring IPVS early career recognition awardee 2023 Tuesday, May 16, 2023 8:00 – 9:00 PDT (Los Angeles) / 17:00 – 18:00 CEST (Geneva) Topic: Join this educational webinar to hear the IPVS early career recognition awardee share her exceptional research. This will be followed by a 35-minute […]
IPVS-IANS Webinar – Strategies for Anal Cancer Prevention: An Update
Joint IANS-IPVS webinar: Strategies for Anal Cancer Prevention – An Update Thursday, 26 September 2024 16:00 – 17:30 CEST (Geneva) / 10:00 – 11:30 EDT (New York) Join us for an insightful webinar on strategies for anal cancer prevention, covering recent epidemiological data and its impact on screening recommendations, research gaps in the treatment of […]
IPVS webinar: Everything you need to know about HPV and pregnancy
IPVS webinar: Everything you need to know about HPV and pregnancy Thursday, 28th April 2022 12:00-13:30 EDT (New York) / 18:00-19:30 CEST (Geneva) Topic: Join our upcoming webinar to learn everything you need to know about HPV and pregnancy. HPV lesion treatment is known to be associated with obstetrical complications and now HPV infection in […]
IPVS webinar: Testing positive for HPV in cervical screening
IPVS webinar Testing positive for HPV in cervical screening: psychosocial and communication issues for patients and providers Friday, 10th June 2022 9:00-10:00 EDT (New York) / 15:00-16:00 CEST (Geneva) Topic: HPV screening is changing the scope of screening from abnormal cells to a virus that is sexually transmitted. Reluctance from health professionals having to counsel […]
IPVS webinar – IPVC 2023 in 60 minutes (Part 1)
IPVS webinar – IPVC 2023 in 60 minutes (Part 1): Birds eye view of conference highlights Wednesday, June 7, 2023 16:30 – 17:30 CEST (Geneva) / 10:30 – 11:30 EDT (New York) Topic: Did you miss IPVC 2023 in Washington DC (April 17-21, 2023)? Or you were probably unable to attend all sessions of the […]
IPVS webinar: Prevention of anal cancer
IPVS webinar Prevention of anal cancer: Will the ANCHOR study be sufficient to start screening programs? Tuesday, 9th August 2022 17:00-18:30 CEST (Geneva) / 11:00-12:30 EDT (New York) Topic: Join international experts in a discussion around prevention of anal cancer. In this session, the speakers will discuss the burden of anal cancer, the clinical findings […]
HPV Screening Tests: How to Make the Best Decision for Your Program
IPVS educational webinar – HPV Screening Tests: How to Make the Best Decision for Your Program Tuesday, 18 February 2025 16:00 CET (Geneva) / 10:00 EST (New York) Topic: Participate in this free educational webinar to discover how to make informed decisions about HPV screening strategies to enhance cervical cancer prevention efforts. This post-IPVC 2024 […]
IPVS webinar: Harnessing immunotherapy to control and/or eliminate HPV associated disease
IPVS webinar: Harnessing immunotherapy to control and/or eliminate HPV associated disease Tuesday, 26 September 2023 10:00-11:30 EDT (New York) / 16:00-17:30 CEST (Geneva) Topic: Join us for an engaging session that aims to educate and explore the practical application of cutting-edge advancements in immunotherapies. In this webinar, we will delve into the realm of […]
Behavioral & Implementation Science in Action: A Case Study of the HPV Vaccine Task Force in Ontario, Canada
IPVS educational webinar: Behavioral & Implementation Science in Action: A Case Study of the HPV Vaccine Task Force in Ontario, Canada Tuesday, 18 March 2025 17:30 CET (Geneva) / 12:30 EST (New York) Topic: Discover how innovative approaches in behavioral and implementation science are transforming HPV immunization efforts in Ontario. Join our experts as […]
Controversies in Anal Cancer Screening
IPVS educational webinar: Controversies in Anal Cancer Screening Wednesday, 9 April 2025 14:00 CEST (Geneva) / 8:00 EDT (New York) Topic: Discover the latest insights and debates surrounding anal cancer screening in this webinar. Our expert panel will discuss key challenges in identifying high-risk populations, the pros and cons of various screening methods, and […]
